[go: up one dir, main page]

NO20075385L - 7-aminoalkylidenyl-heterocykliske kinoloner og naftyridoner - Google Patents

7-aminoalkylidenyl-heterocykliske kinoloner og naftyridoner

Info

Publication number
NO20075385L
NO20075385L NO20075385A NO20075385A NO20075385L NO 20075385 L NO20075385 L NO 20075385L NO 20075385 A NO20075385 A NO 20075385A NO 20075385 A NO20075385 A NO 20075385A NO 20075385 L NO20075385 L NO 20075385L
Authority
NO
Norway
Prior art keywords
aminoalkylidenyl
naphthyridones
quinolones
heterocyclic
heterocyclic quinolones
Prior art date
Application number
NO20075385A
Other languages
English (en)
Other versions
NO340833B1 (no
Inventor
Mark J Macielag
Iii Eugene B Grant
Steven David Paget
Michele Ann Weidner-Wells
Xiaoqing Xu
Xiaodong Xu
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20075385L publication Critical patent/NO20075385L/no
Publication of NO340833B1 publication Critical patent/NO340833B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Foreliggende oppfinnelse angår forbindelser som har strukturen i henhold til formel (I), hvor n, m, z, R, R2, R3, R4, R5, R6, A, E, X, Y, a og b er som definert i beskrivelsen; eller en optisk isomer, diastereomer, enantiomer, farmasøytisk akseptabelt salt, hydrat eller prodrug derav.
NO20075385A 2005-03-21 2007-10-22 7-aminoalkylidenylheterocykliske kinolon- og naftyridon-forbindelser og farmasøytiske sammensetninger NO340833B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/084,987 US7732612B2 (en) 2004-09-09 2005-03-21 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
PCT/US2006/003657 WO2006101603A1 (en) 2005-03-21 2006-02-02 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones

Publications (2)

Publication Number Publication Date
NO20075385L true NO20075385L (no) 2007-12-14
NO340833B1 NO340833B1 (no) 2017-06-26

Family

ID=36648281

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075385A NO340833B1 (no) 2005-03-21 2007-10-22 7-aminoalkylidenylheterocykliske kinolon- og naftyridon-forbindelser og farmasøytiske sammensetninger

Country Status (22)

Country Link
US (1) US7732612B2 (no)
EP (1) EP1861401B1 (no)
JP (1) JP4977684B2 (no)
KR (1) KR101323665B1 (no)
CN (1) CN101248070B (no)
AR (1) AR053342A1 (no)
AU (1) AU2006227984A1 (no)
BR (1) BRPI0609426B8 (no)
CA (1) CA2602140C (no)
CR (1) CR9458A (no)
DK (1) DK1861401T3 (no)
EA (1) EA014554B1 (no)
ES (1) ES2561834T3 (no)
IL (1) IL186041A (no)
MX (1) MX2007011774A (no)
MY (1) MY147638A (no)
NO (1) NO340833B1 (no)
NZ (1) NZ561651A (no)
TW (1) TWI444380B (no)
UA (1) UA93672C2 (no)
WO (1) WO2006101603A1 (no)
ZA (1) ZA200708868B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7913302B2 (en) * 2004-05-02 2011-03-22 Markmonitor, Inc. Advanced responses to online fraud
US20090156577A1 (en) * 2004-09-09 2009-06-18 Benjamin Davis 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
AU2006335042A1 (en) * 2005-10-21 2007-07-19 Glaxo Group Limited Compounds
DE602006013878D1 (de) 2005-12-22 2010-06-02 Glaxo Group Ltd Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel
HRP20110558T1 (hr) * 2006-03-28 2011-09-30 Warner Chilcott Company Malatne soli i polimorfi od (3s, 5s)-7-[3-amino-5-metil-piperidinil]-1-ciklopropil-1, 4-dihidro-8-metoksi-4-okso-3-kinolinkarboksilne kiseline
US7456279B2 (en) * 2006-03-28 2008-11-25 The Procter & Gamble Company Coupling process for preparing quinolone intermediates
ES2524457T3 (es) 2008-05-29 2014-12-09 Bluestar Silicones France Artículo que presenta propiedades antiincrustantes, y destinado a ser utilizado en aplicaciones acuáticas, en particular marinas
US9012634B2 (en) 2011-08-10 2015-04-21 Janssen R&D Ireland Antibacterial piperidinyl substituted 3,4-dihydro-1H-[1,8]naphthyridinones
JO3611B1 (ar) 2011-08-10 2020-08-27 Janssen Sciences Ireland Uc سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم
KR101774044B1 (ko) 2011-09-30 2017-09-01 얀센 파마슈티카 엔.브이. 2-[(2ｅ)-2-플루오로-2-(3-피페리디닐리덴)에틸]-1ｈ-이소인돌-1,3(2h)-디온을 제조하기 위한 개선된 방법
EP2928892B1 (en) * 2012-12-04 2018-03-21 Mankind Pharma Ltd. An improved process for the preparation of moxifloxacin hydrochloride
WO2016079757A2 (en) * 2014-11-19 2016-05-26 Symed Labs Limited Novel processes for preparing 5-hydroxymethyl-oxazolidin-2-one derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO871333L (no) 1986-03-31 1987-10-01 Sankyo Co Kinolin-3-karboksylsyrederivater, fremgangsmaate til fremstilling og anvendelse derav.
JPH0262875A (ja) * 1988-05-23 1990-03-02 Wakunaga Pharmaceut Co Ltd 新規イソインドリン誘導体
CA1332605C (en) * 1988-10-03 1994-10-18 Yasuhiro Nishitani Pyridonecarboxylic acids
US5580872A (en) * 1990-05-02 1996-12-03 Abbott Laboratories Quinolizinone type compounds
FR2692577B1 (fr) * 1992-05-26 1996-02-02 Bouchara Sa Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
NO304832B1 (no) * 1992-05-27 1999-02-22 Ube Industries Aminokinolonderivater samt middel mot HIV
JPH07300472A (ja) * 1992-12-28 1995-11-14 Korea Res Inst Chem Technol 新規キノロンカルボン酸誘導体およびその製造方法
JPH06263754A (ja) 1993-03-12 1994-09-20 Hokuriku Seiyaku Co Ltd ７−アミノピロリジニルキノリン−３−カルボン酸誘導体
JP4669607B2 (ja) * 1997-09-15 2011-04-13 ザ プロクター アンド ギャンブル カンパニー 抗微生物キノロン類、その組成物およびその使用
US6964966B2 (en) 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US6878713B2 (en) * 2001-04-25 2005-04-12 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
JP2007522093A (ja) * 2003-09-22 2007-08-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ７−アミノアルキリデニル−複素環式キノロンおよびナフチリドン

Also Published As

Publication number Publication date
US7732612B2 (en) 2010-06-08
BRPI0609426A2 (pt) 2010-04-06
CA2602140C (en) 2015-04-14
CA2602140A1 (en) 2006-09-28
TWI444380B (zh) 2014-07-11
US20060052359A1 (en) 2006-03-09
CN101248070A (zh) 2008-08-20
TW200700418A (en) 2007-01-01
BRPI0609426B1 (pt) 2020-09-24
JP4977684B2 (ja) 2012-07-18
IL186041A (en) 2016-05-31
CR9458A (es) 2008-09-09
EA014554B1 (ru) 2010-12-30
NZ561651A (en) 2011-09-30
BRPI0609426B8 (pt) 2021-05-25
KR20070113304A (ko) 2007-11-28
CN101248070B (zh) 2011-12-14
JP2008538110A (ja) 2008-10-09
MX2007011774A (es) 2008-03-10
AU2006227984A1 (en) 2006-09-28
AR053342A1 (es) 2007-05-02
DK1861401T3 (en) 2015-12-07
NO340833B1 (no) 2017-06-26
ES2561834T3 (es) 2016-03-01
EA200702039A1 (ru) 2008-02-28
KR101323665B1 (ko) 2013-10-31
WO2006101603A1 (en) 2006-09-28
EP1861401A1 (en) 2007-12-05
ZA200708868B (en) 2009-01-28
IL186041A0 (en) 2008-02-09
UA93672C2 (en) 2011-03-10
MY147638A (en) 2012-12-31
EP1861401B1 (en) 2015-11-18

Similar Documents

Publication Publication Date Title
NO20075385L (no) 7-aminoalkylidenyl-heterocykliske kinoloner og naftyridoner
WO2007016392A3 (en) Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
PE20081530A1 (es) Nuevos compuestos 617
NO20084583L (no) Makrosykliske kinase-inhibitorer
WO2005074603A3 (en) Aminobenzoxazoles as therapeutic agents
CY1109424T1 (el) 7-αμινο αλκυλιδενυλ-ετεροκυκλικες κινολονες και ναφθυριδονες
BRPI0615705A2 (pt) processo para preparar um composto, e, composto
WO2008005368A3 (en) Piperazines as p2x7 antagonists
NO20081930L (no) Oksazolforbindelser og farmasoytiske blandinger
SE0400284D0 (sv) Novel compounds
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
NO20076145L (no) Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav
CY1113320T1 (el) Σπειρο-κυκλικα νιτριλια ως αναστολεις πρωτεασης
ATE360045T1 (de) Polycarbonatzusammensetzungen
EA200970372A1 (ru) Ингибитор развития болезни альцгеймера, содержащий гетероциклическое соединение
WO2006113509A3 (en) Quinobenzoxazine analogs and methods of using thereof
EA200801199A1 (ru) Ингибиторы киназы
NO20084543L (no) Benzimidazolderivater
DK1954690T3 (da) Benzamidforbindelser, der er anvendelige som inhibitorer af histondeacetylase
WO2010056633A8 (en) 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
MA32834B1 (fr) 3-aminocyclopentanecarboxamides servant de modulateurs de recepteurs de chimiokines
DE602005011784D1 (de) Pyrazoloä4,3-düpyrimidine
EA200870038A1 (ru) Способ получения аминов
DK1301475T3 (da) Arylsulfonamider, som serotoninantagonist til behandling af obesitet
EA200600760A1 (ru) Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees